From: Sex differences in cancer survival in Estonia: a population-based study
No. of cases (%) | ||||
---|---|---|---|---|
Cancer site | Age at diagnosis (years) | Men | Women | p-value* |
Mouth, pharynx | <45 | 76 (5) | 35 (8) | p < 0.001 |
45–54 | 317 (23) | 60 (13) | ||
55–64 | 503 (36) | 92 (20) | ||
65–74 | 379 (27) | 128 (28) | ||
≥75 | 120 (9) | 136 (30) | ||
Stomach | <45 | 140 (5) | 126 (5) | p < 0.001 |
45–54 | 377 (13) | 248 (10) | ||
55–64 | 756 (26) | 440 (18) | ||
65–74 | 1067 (37) | 801 (33) | ||
≥75 | 557 (19) | 797 (33) | ||
Colon | <45 | 54 (3) | 73 (3) | p < 0.001 |
45–54 | 159 (8) | 183 (7) | ||
55–64 | 456 (23) | 498 (18) | ||
65–74 | 809 (41) | 970 (36) | ||
≥75 | 496 (25) | 988 (36) | ||
Rectum | <45 | 44 (3) | 56 (4) | p < 0.001 |
45–54 | 134 (8) | 131 (8) | ||
55–64 | 428 (27) | 307 (19) | ||
65–74 | 641 (40) | 531 (34) | ||
≥75 | 356 (22) | 227 (35) | ||
Pancreas | <45 | 56 (5) | 20 (2) | p < 0.001 |
45–54 | 18 (13) | 76 (7) | ||
55–64 | 318 (28) | 184 (18) | ||
65–74 | 414 (36) | 350 (34) | ||
≥75 | 206 (18) | 405 (39) | ||
Lung | <45 | 132 (2) | 43 (3) | p < 0.001 |
45–54 | 785 (11) | 159 (10) | ||
55–64 | 2131 (31) | 334 (20) | ||
65–74 | 2859 (41) | 610 (37) | ||
≥75 | 1041 (15) | 501 (30) | ||
Skin melanoma | <45 | 98 (18) | 188 (19) | p = 0.076 |
45–54 | 75 (14) | 147 (15) | ||
55–64 | 130 (24) | 199 (20) | ||
65–74 | 147 (28) | 239 (25) | ||
≥75 | 83 (16) | 199 (20) | ||
Kidney | <45 | 86 (5) | 38 (3) | p < 0.001 |
45–54 | 286 (18) | 130 (11) | ||
55–64 | 472 (29) | 302 (25) | ||
65–74 | 544 (34) | 433 (36) | ||
≥75 | 229 (14) | 290 (24) | ||
Bladder | <45 | 45 (3) | 18 (3) | p < 0.001 |
45–54 | 137 (8) | 33 (5) | ||
55–64 | 388 (22) | 86 (13) | ||
65–74 | 702 (40) | 212 (32) | ||
≥75 | 488 (28) | 310 (47) |